Ameet Sarpatwari

Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States.

Walsh BS, Sarpatwari A, Rome BN, Kesselheim AS.

JAMA Intern Med. 2021 Jul 01. 181(7):995-997. PMID: 33779681

Cost to Medicare of Delayed Adalimumab Biosimilar Availability.

Lee CC, Najafzadeh M, Kesselheim AS, Sarpatwari A.

Clin Pharmacol Ther. 2021 Jun 18. PMID: 34145566

Civil commitment for opioid misuse: do short-term benefits outweigh long-term harms?

Messinger JC, Ikeda DJ, Sarpatwari A.

J Med Ethics. 2021 May 27. PMID: 34045279

Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition Unclear.

Sarpatwari A, Tessema FA, Zakarian M, Najafzadeh MN, Kesselheim AS.

Health Aff (Millwood). 2021 05. 40(5):772-778. PMID: 33939506

A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs.

Sarpatwari A, Mitra-Majumdar M, Bykov K, Avorn J, Woloshin S, Toyserkani GA, LaCivita C, Manzo C, Zhou EH, Pinnow E, Dal Pan GJ, Gagne JJ, Huybrechts KF, Feldman WB, Chin K, Kesselheim AS.

Drug Saf. 2021 Jul. 44(7):743-751. PMID: 33904111

Identifying potential prescription drug product hopping.

Gowda V, Beall RF, Kesselheim AS, Sarpatwari A.

Nat Biotechnol. 2021 04. 39(4):414-417. PMID: 33846649

Substitution of Generic Drugs and Biosimilars-Reply.

Sarpatwari A, Kesselheim AS, Sacks CA.

JAMA Intern Med. 2021 Apr 01. 181(4):568. PMID: 33492341

Corrections to Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.

Sarpatwari A.

JAMA Intern Med. 2021 Jan 01. 181(1):144. PMID: 33252639

A Non-Profit Approach to Address Foreign Dependence of Generic Drugs.

Liljenquist D, Bai G, Sarpatwari A, Anderson GF.

J Law Med Ethics. 2021. 49(1):30-33. PMID: 33966649

INTRODUCTION: Public Sector and Non-Profit Contributions to Drug Development - Historical Scope, Opportunities, and Challenges.

Sarpatwari A, Kesselheim AS.

J Law Med Ethics. 2021. 49(1):6-9. PMID: 33966663